Matt, Author at European Medical Journal - Page 58 of 212

Continue
6 Jul 2020

Latest scientific research presented at 2020 AAD congress - Vichy Laboratoires

In this webinar, six renowned dermatologists from Chile, Argentina, Germany, Italy, Canada and France will share the latest scientific research presented at last AAD congress.
29 Jun 2020

The Benefits of Expanded Carrier Screening in IVF Research

In this webinar, Dr Dagan Wells discusses the benefits of expanded carrier screening, focussing on the advantages of carrier screening in IVF research and how this might alter workflows.
2 Mins
29 Jun 2020

Traumatic Coronary Artery Dissection Diagnosed Immediately with Cardiac CT

The incidence of traumatic coronary artery dissection is rare, but it can be life-threatening…
3 Mins
23 Jun 2020

Newborn Screening: Now and in the Future

WHAT is the value of newborn screening (NBS) to the rare diseases community?…
2 Mins
23 Jun 2020

Driving Care Pathways into the Future

ARTIFICIAL intelligence could one day form the backbone of healthcare, but with such a powerful technology looming on our horizon, what exactly does…
3 Mins
23 Jun 2020

Disruptive Innovations in Clinical Research

New trends in clinical research and trial design were discussed, as well as challenges associated with the need to perform innovatively to advance…
8 Mins
23 Jun 2020

Early Intervention with Anti-Tumour Necrosis Factor in Ulcerative Colitis: The Missing Piece of The Puzzle?

In an interactive symposium moderated by Dr Cummings, the question: “Is early intervention with anti-TNF the key to achieving long-lasting remission…
8 Mins
23 Jun 2020

Eicosapentaenoic Acid: Atheroprotective Properties and the Reduction of Atherosclerotic Cardiovascular Disease Events

Atherosclerosis is an inflammatory disease and inflammation is crucial to all stages of atherogenesis. Targeting inflammation has the potential to reduce…
6 Mins
23 Jun 2020

Chlormethine Gel for Mycosis Fungoides T-cell Lymphoma: Recent Real-World Data

An enhanced understanding of real-world CL Gel usage could help improve the management of patients with MF-CTCL…
6 Mins
23 Jun 2020

Data from the AUGUSTUS Trial Adds an Important Piece to the Complex Puzzle of Antithrombotic Treatment for Those with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention

AF can increase stroke risk and is generally treated with OAC therapy, such as with a VKA or a direct OAC (DOAC). However, what if someone with AF…
We’ve noticed you’re accessing
from North/South America.